Cabaletta Bio: Guggenheim Keeps Buy Rating, Raises PT to $16.

martes, 24 de marzo de 2026, 9:33 am ET1 min de lectura
CABA--

Cabaletta Bio: Guggenheim Keeps Buy Rating, Raises PT to $16.

Cabaletta Bio: Guggenheim Keeps Buy Rating, Raises PT to $16.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios